Cover Image

Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae

Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a substantial healthcare challenge. This study assessed the in vitro efficacy of selected antibiotic combinations against CRKP infections. Methods: Our research involved the evaluation of 40 clinical isolates of CRKP, with half expr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu-Shan Huang (Author), Jia-Ling Yang (Author), Jann-Tay Wang (Author), Wang-Huei Sheng (Author), Chia-Jui Yang (Author), Yu-Chung Chuang (Author), Shan-Chwen Chang (Author)
Format:	Book
Published:	Elsevier, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Activity of carbapenems and tigecycline against ESBL-producing Escherichia coli and Klebsiella spp.
by: Caio Fernando de Oliveira, et al.
Published: (2018)

The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <em>Klebsiella pneumoniae</em> Isolates
by: Parnrada Nulsopapon, et al.
Published: (2021)

Impact of Tigecycline's MIC in the Outcome of Critically Ill Patients with Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Bacteraemia Treated with Tigecycline Monotherapy-Validation of 2019's EUCAST Proposed Breakpoint Changes
by: Matthaios Papadimitriou-Olivgeris, et al.
Published: (2020)

Proteomic analysis of carbapenem-resistant Klebsiella pneumoniae outer membrane vesicles under the action of phages combined with tigecycline
by: Jing Mao, et al.
Published: (2024)

A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains
by: Yi-Chien Lee, et al.
Published: (2019)

Tigecycline Therapy for Infections Caused by Extended-Spectrum β-Lactamase-Producing <i>Enterobacteriaceae</i> in Critically Ill Patients
by: Wen-Liang Yu, et al.
Published: (2020)

Characterisation of Non-Carbapenemase-Producing Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Based on Their Clinical and Molecular Profile in Malaysia
by: Yee Qing Lee, et al.
Published: (2022)

Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization
by: Ihn Sook Jeong, et al.
Published: (2022)

Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients
by: Monica Taminato, et al.

First Description of Colistin and Tigecycline-Resistant <i>Acinetobacter baumannii</i> Producing KPC-3 Carbapenemase in Portugal
by: Cátia Caneiras, et al.
Published: (2018)

Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman
by: Mohammed Al Balushi, et al.
Published: (2022)

Emergence of carbapenemase-producing Klebsiella pneumoniae of sequence type 258 in Michigan, USA
by: Ruchika Jain, et al.
Published: (2013)

Antimicrobial activity and mode of action of terpene linalyl anthranilate against carbapenemase-producing Klebsiella pneumoniae
by: Shun-Kai Yang, et al.
Published: (2021)

Susceptibility of Tigecycline against Carbapenem Resistant Enterobacteriaceae
by: Madeeha Fatima, et al.
Published: (2024)

Secondary bacterial infection caused by ST16 NDM-1 and OXA-48-producing colistin and carbapenem-resistant Klebsiella pneumoniae treated with tigecycline in a pregnant woman with COVID-19
by: Samaneh Pourajam, et al.
Published: (2023)

Emergência de Klebsiella pneumoniae produtora de carbapenemase (KPC) em um hospital terciário Emergence of Klebsiella pneumoniae carbapenemase-producing (KPC) in a tertiary hospital
by: Valéria Martins Soares
Published: (2012)

Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review
by: David M. Jacobs, et al.
Published: (2017)

In Vivo Pharmacodynamics of β-Lactams/Nacubactam against Carbapenem-Resistant and/or Carbapenemase-Producing <i>Enterobacter cloacae</i> and <i>Klebsiella pneumoniae</i> in Murine Pneumonia Model
by: Mao Hagihara, et al.
Published: (2021)

SG-APSIC1159: Control of hospital-acquired carbapenemase-producing carbapenem-resistant Enterobacteriaceae colonization: A descriptive study
by: Tuodi Wu, et al.
Published: (2023)

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing <i>Klebsiella pneumoniae</i> in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination
by: Alla V. Filimonova, et al.
Published: (2021)

Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model
by: Maria V. Golikova, et al.
Published: (2023)

Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing <i>Klebsiella pneumoniae</i> in Colombia
by: Elsa De La Cadena, et al.
Published: (2021)

Surveillance of Antimicrobial Resistance in Hospital Wastewater: Identification of Carbapenemase-Producing <i>Klebsiella</i> spp.
by: Miguel Galarde-López, et al.
Published: (2022)

Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals
by: Mohamed H. Al-Agamy, et al.
Published: (2018)

Efficacies of Colistin-Carbapenem versus Colistin-Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021)

Characteristics of dual carbapenemase-producing Klebsiella pneumoniae strains from an outbreak in Venezuela: a retrospective study
by: Dianny Martínez, et al.
Published: (2020)

Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: A pilot study
by: Amin A. Aqel, et al.
Published: (2017)

Formulation of phage cocktails and evaluation of their interaction with antibiotics in inhibiting carbapenemase-producing Klebsiella pneumoniae in vitro in Kenya
by: Noutin F. Michodigni, et al.
Published: (2022)

Wastewaters, with or without Hospital Contribution, Harbour MDR, Carbapenemase-Producing, but Not Hypervirulent <i>Klebsiella pneumoniae</i>
by: Adela Teban-Man, et al.
Published: (2021)

Similarity Analysis of <i>Klebsiella pneumoniae</i> Producing Carbapenemases Isolated from UTI and Other Infections
by: Agata Pruss, et al.
Published: (2023)

Correction: Nulsopapon et al. The Synergistic Activity and Optimizing Doses of Tigecycline in Combination with Aminoglycosides against Clinical Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Isolates. <i>Antibiotics</i> 2021, <i>10</i>, 736
by: Parnrada Nulsopapon, et al.
Published: (2022)

Carbapenemase-Producing Enterobacterales
Published: (2022)

Evaluation of the Therapeutic Outcomes of Antibiotic Regimen Against Carbapenemase-Producing Klebsiella pneumoniae: A Systematic Review and Meta-Analysis
by: Clement Yaw Effah, et al.
Published: (2021)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing <i>Pseudomonas aeruginosa</i>: Experimental In Vitro and In Vivo Analysis
by: Soraya Herrera-Espejo, et al.
Published: (2022)

Corrigendum: Formulation of phage cocktails and evaluation of their interaction with antibiotics in inhibiting carbapenemase-producing Klebsiella pneumoniae in vitro in Kenya
by: Noutin F. Michodigni, et al.
Published: (2023)

Polyclonal Endemicity of Carbapenemase-Producing <i>Klebsiella pneumoniae</i> in ICUs of a Greek Tertiary Care Hospital
by: Efthymia Protonotariou, et al.
Published: (2022)

Carbapenemase Producing <i>Klebsiella pneumoniae</i> (KPC): What Is the Best MALDI-TOF MS Detection Method
by: Lukáš Hleba, et al.
Published: (2021)

Clinical Usefulness of Klebsiella Pneumoniae Carbapenemase-Producing K. Pneumoniae Genotyping: The Experience of a Single-Center Epidemic
by: Marianna Rossi, et al.
Published: (2017)

Detection of carbapenem-resistant Klebsiella pneumoniae strains harboring carbapenemase, beta-lactamase and quinolone resistance genes in intensive care unit patients
by: Unlu, Ozge, et al.
Published: (2020)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
by: Rémy A. Bonnin, et al.
Published: (2023)